drugset / Trial / NCT01404962

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

NCT01404962 ↗

Phase 4 Completed 764 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This is a multicenter, post marketing surveillance study which aims to evaluate the safety profile of haemophilus influenza type b vaccine when administered to Korean children according to the product insert.

Timeline

Start
2011-08
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Haemophilus influenza type b conjugate vaccine Vaccine — —